Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease - Wikidata - awgldk - TriplyDB

Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease

Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease

http://www.wikidata.org/entity/Q35734988

about

Lipoxins: nature's way to resolve inflammation RAGE: a new frontier in chronic airways disease Advances in understanding COPD Resolvin D1 attenuates polyinosinic-polycytidylic acid-induced inflammatory signaling in human airway epithelial cells via TAK1 DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation Specialized pro-resolving mediators: endogenous regulators of infection and inflammation Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7 Integrating murine gene expression studies to understand obstructive lung disease due to chronic inhaled endotoxin Resolution of acute inflammation in the lung SAA drives proinflammatory heterotypic macrophage differentiation in the lung via CSF-1R-dependent signaling.Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults Role of alveolar macrophages in chronic obstructive pulmonary disease.IL-17A and serum amyloid A are elevated in a cigarette smoke cessation model associated with the persistence of pigmented macrophages, neutrophils and activated NK cells Preliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patients.Targeting pro-resolution pathways to combat chronic inflammation in COPD Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists Serum amyloid A as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis S100A12 suppresses pro-inflammatory, but not pro-thrombotic functions of serum amyloid A.Characterization of the oligomerization and aggregation of human Serum Amyloid A Acute-phase serum amyloid a in osteoarthritis: regulatory mechanism and proinflammatory properties.Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis.Wood smoke enhances cigarette smoke-induced inflammation by inducing the aryl hydrocarbon receptor repressor in airway epithelial cells Serum Amyloid A Induces Toll-Like Receptor 2-Dependent Inflammatory Cytokine Expression and Atrophy in C2C12 Skeletal Muscle Myotubes.Airway epithelial regulation of allergic sensitization in asthma.Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation.Serum amyloid A, protein Z, and C4b-binding protein β chain as new potential biomarkers for pulmonary tuberculosis Resolvin D1 and Resolvin E1 Promote the Resolution of Allergic Airway Inflammation via Shared and Distinct Molecular Counter-Regulatory Pathways.Resolvin D1 Reduces Emphysema and Chronic Inflammation.An investigation of the resolution of inflammation (catabasis) in COPD.COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link.Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection.C-reactive protein and serum amyloid a overexpression in lung tissues of chronic obstructive pulmonary disease patients: a case-control study.Exhaled breath condensate eicosanoid levels associate with asthma and its severity.Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD)Serum amyloid A promotes lung neutrophilia by increasing IL-17A levels in the mucosa and γδ T cells.Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses.Biasing the lipoxin A4/formyl peptide receptor 2 pushes inflammatory resolution.Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.Modulation of Neutrophil Apoptosis and the Resolution of Inflammation through β2 Integrins.Pulmonary biomarkers in COPD exacerbations: a systematic review.

P2860

Q26784376-58534734-1580-4BE2-8269-D99032F3BD76 Q27025295-2910E50C-6D72-4BD0-BEEE-99A694E0C094 Q28074701-E9500B3F-B29B-4278-B0BB-B3AE68B6724B Q28249812-65207837-2716-4616-A114-0FAD396850B8 Q28269550-EE27F2D5-4C70-4E24-8542-0B32C6AC5CA8 Q28271331-D76B84BA-E238-4EF4-AE79-02C405F4C8EF Q28308192-37A137DB-2095-47A3-B5AA-C78EF253173C Q28382913-72A85DF9-3B91-4484-90B9-586F4BD461B9 Q28652204-83ECDEB2-C4E0-44B5-9B53-A8C9CB7E0F96 Q33576194-261AA26C-05C5-4695-8820-CA9E098913CE Q33604867-020DB468-19C0-4EE9-8B1E-471D08940C27 Q34159624-1CB013E5-6563-4779-8352-AE993B0210AA Q34535911-F9B7FF08-C3EC-4DA4-9EAD-66E644116984 Q34582445-9CA0820C-926E-4327-A818-2E6F2F4AC2A8 Q34628609-7239161B-C61C-409C-99CB-6DEFC4EEE16E Q34645842-37824C1F-D605-48D2-953B-64E821E68897 Q34697924-3CD3312C-9696-4442-98DB-7CB5CD744915 Q34701317-6EF62767-71C7-4EA8-B402-E49DE32C8F9D Q34764150-50A7636C-24DE-41AB-9DC8-375D4693DAA1 Q34776878-569DF378-D23A-4A3B-8613-0FF987C28A48 Q35064030-DDA0FDDD-2776-4868-8263-DC72CC90E1AF Q35207731-E75E8DDE-108E-4E4F-B84D-0AF3CA6D0CE3 Q35897585-A3D92E37-2D07-4509-9945-3BB11CBCAA6A Q36183332-09258212-1D9A-4FE0-A7AD-421BE7FC6094 Q36236176-7E8E06D5-7824-407D-87FB-D2C7D6A03446 Q36302326-79EE41DB-7E76-49E6-A7EB-CBF58313B745 Q36492325-2E1A283B-227F-4956-A0B4-EA42CE1758F0 Q36509194-D8EC8152-2C90-4C69-8B65-E4E7D31818E5 Q36539037-0B1239B9-126E-4AA6-B251-1796C88AA6E7 Q36546997-0776CA3F-31B8-4D40-B984-5AB00C06A991 Q36549032-364A9292-2A52-490E-9CCD-49DCC5017F72 Q36953097-8AE995D3-4FD9-494C-A0DB-89A7B915E6A2 Q37138368-F949EF26-0D6E-48DA-B935-DBAE73CC4045 Q37158751-587B5BDA-3BED-47BD-974C-6A5FCB8403E3 Q37186995-BC9F24BE-AD3F-43C0-88DE-F9E128F60E6B Q37318064-BC2F6D7C-6E0E-4458-847E-EAF4D284EF5E Q37318177-7A2C057F-8D0A-4538-8FED-FAC33783DE7B Q38066413-EADD8FF5-C7A8-43E3-944D-015D317B7FFD Q38091028-B94AD625-4766-4294-85BC-8B8EA6E21470 Q38154291-823139DB-34ED-4AA5-AB56-09F44E87F8CA

P2860

Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease

http://www.wikidata.org/entity/Q35734988

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Serum amyloid A opposes lipoxi ...... obstructive pulmonary disease

@ast

Serum amyloid A opposes lipoxi ...... obstructive pulmonary disease

@en

type

label

Serum amyloid A opposes lipoxi ...... obstructive pulmonary disease

@ast

Serum amyloid A opposes lipoxi ...... obstructive pulmonary disease

@en

prefLabel

Serum amyloid A opposes lipoxi ...... obstructive pulmonary disease

@ast

Serum amyloid A opposes lipoxi ...... obstructive pulmonary disease

@en

P1433

Q35734988-8D4D4491-DD78-463F-8D50-91A70EF5D525

P1476

Q35734988-B6CB8ED1-AF6F-4660-B1A0-BE243685AC2E

P2093

Q35734988-28BAAA9F-80ED-4CC1-81D1-1D1D6D1C6A97

Q35734988-4C748FFD-B6BF-44BB-B1DC-F32D1B6DDB1D

Q35734988-6407C150-AD3A-4BC2-BD6F-E40F9EFA04C7

Q35734988-89003096-852B-4CE6-A8D1-98E290F2B3F4

Q35734988-E20AFB2E-0A11-49E0-B346-F92CC33283E9

Q35734988-E2ACAB73-C3A8-4136-B33C-8B469E846F5E

Q35734988-EE3ED275-48F2-413F-B27B-5ED3EEB47D87

P2860

Q35734988-02647C99-ED91-4A65-90B9-23F2C6544407

Q35734988-07A5D4AC-929D-4E71-831F-7A210F778427

Q35734988-09671A0C-93B9-4729-8629-818D4E89B4F3

Q35734988-0F1E4885-4355-4B41-8FEE-12F9A9EC1A80

Q35734988-135C1B36-1088-40CF-B9AE-5624648826A0

Q35734988-1BB597FE-AA06-4D98-BB2D-E7FE5B09A5D1

Q35734988-1D44C41B-6556-46B8-831A-1B2F84745409

Q35734988-210580E6-81EE-4DC0-BDD7-B816D0CAD016

Q35734988-23BBB7C2-052F-405B-95CA-E1E3EBFA7DAE

Q35734988-2639EFDA-F0E3-47AD-9985-5557708FA544

P304

Q35734988-14EC75B0-61DD-4B1E-978C-7D7D8A50EA71

P31

Q35734988-BBE3C450-E1C3-4906-9FCF-FC64F79F40AC

P356

Q35734988-30BCE327-09C5-4375-B0A6-EF9AECA237CB

P407

Q35734988-127AC9A4-BB32-4122-BA99-98A284D64AD5

P433

Q35734988-D6BB7406-495C-46CA-945D-083B1A9A2630

P478

Q35734988-2DFC1E06-4FAC-4C6E-9F00-6BB005E4CBFF

P50

Q35734988-41ED3A19-9A7D-4C36-88DF-3183622AE5D4

Q35734988-438D7452-F049-436A-9248-27F403490989

Q35734988-67D99698-CF27-49F2-B29A-056C0C8B10A7

Q35734988-85B68803-1344-4CAF-88B5-9412660F9477

P577

Q35734988-031DDC49-2C16-4ECD-B040-EDD9233E5E1B

P5875

Q35734988-CB333005-4F77-4360-9F07-29E18D7DC35C

P698

Q35734988-DDEF6218-3D25-4A8D-913D-4180A0146C42

P921

Q35734988-8745A73C-E709-4937-B863-67690488CFFE

Q35734988-B2AD660B-5E48-421F-9ACA-6126045A3A6E

P932

Q35734988-79D8C3C8-E973-40EF-9A36-837B7B0A9A26

P356

PNAS.1109382109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Serum amyloid A opposes lipoxi ...... obstructive pulmonary disease

@en

P2093

Anne-Sophie Merritt

http://www.w3.org/2001/XMLSchema#string

Bruce D Levy

http://www.w3.org/2001/XMLSchema#string

Gary P Anderson

http://www.w3.org/2001/XMLSchema#string

Jonathan L McQualter

http://www.w3.org/2001/XMLSchema#string

Louis B Irving

http://www.w3.org/2001/XMLSchema#string

Michelle Thompson

http://www.w3.org/2001/XMLSchema#string

Ross Vlahos

http://www.w3.org/2001/XMLSchema#string

P2860

A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells

Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor

The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo

Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R

Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation

Is serum amyloid A an endogenous TLR4 agonist?

Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A

Nonexpression of the human serum amyloid A three (SAA3) gene

Resolution of inflammation: the beginning programs the end

Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease.

P304

935-940

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1109382109

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Steven Bozinovski

Anastasia Hutchinson

P577

2012-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51980464

http://www.w3.org/2001/XMLSchema#string

P698

22215599

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

3271884

http://www.w3.org/2001/XMLSchema#string